Abstract
The minor tobacco alkaloids nornicotine, anabasine, and anatabine fromNicotiana tobacum are known to possess nicotinic receptor agonist activity, although they are relatively less potent than S-(−)-nicotine, the principal tobacco alkaloid. Previous pharmacological investigations and structure-activity studies have been limited owing to the lack of availability of the optically pure forms of these minor alkaloids. We now report a 2-step synthetic procedure for the enantioselective synthesis of the optical isomers of nornicotine and anabasine, and a modified procedure for the synthesis of anatabine enantiomers. These procedures involve initial formation of the chiral ketimine resulting from the condensation of either 1R, 2R, 5R-(+)- or 1S, 2S, 5S-(−)-2-hydroxy-3-pinanonewith3-(aminomethyl)pyridine followed by enantioselective C-alkylation with an appropriate halogenoalkane or halogenoalkene species, N-deprotection, and base-catalyzed intramolecular ring closure, to form the appropriate, chirally pure minor tobacco alkaloid. Using this approach, theR-(+)-andS-(−)-enantiomers of the above minor tobacco alkaloids were obtained in good overall chemical yield and excellent enantomeric excess.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bush LH, Hempfling WP, Burton H. Chemical properties of nicotine and other tobacco-related compounds. In: Gorrod JW, Jacob P, III, eds.Analytical Determination of Nicotine and Related Compounds and Their Metabolites. New York, NY: Elsevier, 1999:69–147.
Armstrong DW, Wang X, Lee JT, Liu YS. Enantiomeric composition of nornicotine, anatabine, and anabasine in tobacco.Chirality. 1999;11:82–84.
Crooks PA, Godin CS, Pool WF. Enantiomeric purity of nicotine in tobacco smoke.Med Sci Res. 1992;20:879–880.
Crooks PA, Dwoskin LP. Contribution of CNS nicotine metabolites to the neuropharmacological effects of nicotine and tobacco smoking.Biochem Pharmacol. 1997;54:743–753.
Copeland JR, Adem A, Jacob P III, Nordberg A. A comparison of the binding of nicotine and nornicotine stereoisomers to nicotinic binding sites in rat brain cortex.Naunyn Schmiedebergs Arch Pharmacol. 1991;343:123–127.
Reavill C, Jenner P, Kumar R, Stolerman IP. High affinity binding of [3H](−)-nicotine to rat brain membranes and its inhibition by analogues of nicotine.Neuropharmacology. 1988;27:235–241.
Xu R, Dwoskin LP, Grinevich VP, Deacine G, Crooks PA. Neuronal nicotinic acetylcholine receptor binding affinities of boron-containing nicotine analogues.Bioorg Med Chem Lett. 2001;11:1245–1248.
Bardo MT, Bevins RA, Klebaur JE, Crooks PA, Dwoskin LP. Nornicotine partially substitutes for (+)-amphetamine in a drug discrimination paradigm in rats.Pharmacol Biochem Behav. 1997;58:1083–1087.
Green TA, Phillips SB, Crooks PA, Dwoskin LP, Bardo MT. Nornicotine pretreatment decreases intravenous nicotine self-administration in rats.Psychopharmacology (Berl). 2000;152:289–294.
Green TA, Crooks PA, Bardo MT, Dwoskin LP. Contributory role for nornicotine neuropharmacology: nornicotine-evoked [3H]dopamine overflow from rat nucleus accumbens slices.Biochem Pharmacol. 2001;62:1597–1603.
Dwoskin LP, Buxton ST, Jewell AL, Crooks PA. (−)-Nornicotine increases dopamine release in a calcium-dependent manner from superfused rat striatal slices.J Neurochem. 1993;60:2167–2174.
Teng L, Crooks PA, Buxton ST, Dwoskin LP. Nicotinic-receptor mediation of S(−)nornicotine-evoked-3H-overflow from rat striatal slices preloaded with-3H-dopamine.J Pharmacol Exp Ther. 1997;283:778–787.
Kyerematen GA, Morgan M, Chattopadhyay B, deBethizy JD, Vesell ES. Disposition of nicotine and eight metabolites in smokers and nonsmokers: identification in smokers of two metabolites that are longer lived than cotinine.Clin Pharmacol Ther. 1990;48:641–651.
Crooks PA, Li M, Dwoskin LP. Metabolites of nicotine in rat brain after peripheral nicotine administration: cotinine, nornicotine, and norcotinine.Drug Metab Dispos. 1997;25:47–54.
Ghosheh O, Dwoskin LP, Li WK, Crooks PA. Residence times and half-lives of nicotine metabolites in rat brain after acute peripheral administration of [2′-14C]nicotine.Drug Metab Dispos. 1999;27:1448–1455.
Valette H, Bottlaender M, Dollé F, Coulon C, Ottaviani M, Syrota A. Long-lasting occupancy of central nicotine acetylcholine receptors after smoking: a PET study in monkeys.J Neurochem. 2003;84:105–111.
Ghosheh O, Dwoskin LP, Miller DK, Crooks PA. Accumulation of nicotine and its metabolites in rat brain after intermittent or continuous peripheral administration of [2′-14C]-nicotine.Drug Metab Dispos. 2001;29:645–651.
Risner ME, Cone EJ, Benowitz NL, Jacob P III. Effects of stereoisomers of nicotine and nornicotine on schedule controlled responding by beagle dogs and squirrel monkeys.J Pharmacol Exp Ther. 1988;244:807–813.
Bardo MT, Green TA, Crooks PA, Dwoskin LP. Nornicotine is self-administered intravenously by rats.Psychopharmacology (Berl). 1999;146:290–296.
Corrigall WA, Coen KM. Nicotine maintains robust self-administration in rats on a limited-access schedule.Psychopharmacology (Berl). 1989;99:473–478.
Middleton LS, Crooks PA, Wedlund PJ, Cass WA, Dwoskin LP. Nornicotine inhibition of striatal dopamine transporter function via nicotinic receptor activation.J Pharmacol Exp Ther. 2005.
Crooks PA, Dwoskin LP, Bardo MT, inventor. Nornicotine enantiomers for use as a treatment for dopamine-related conditions and disease states. US patent 5776957. July 8, 1998.
Dwoskin LP, Teng L, Buxton ST, Ravard A, Deo N, Crooks PA. Minor tobacco alkaloids release [3H]dopamine from superfused rat striatal slices.Eur J Pharmacol. 1995;276:195–199.
Grady S, Marks MJ, Wonnacott S, Collins AC. Characterization of nicotinic receptor-mediated [3H]dopamine release from synaptosomes prepared from mouse striatum.J Neurochem. 1992;59:848–856.
Crooks PA. Chemical properties of nicotine and other tobacco-related compounds. In: Gorrod JW, Jacob P, eds.Analytical Determination of Nicotine and Related Compounds and Their Metabolites. New York, NY: Elsevier, 1999;69–147.
Deo NM, Crooks PA. Regioselective alkylation of N-(diphenylmethylidine)-3-(aminomethyl)pyridine: a simple route to minor tobacco alkaloids and related compounds.Tetrahedron Lett. 1996;37:1137–1140.
Yus M, Soler T, Foubelo F. A new and direct synthesis of 2-substituted pyrrolidines.J Org Chem. 2001;66:6207–6208.
Loh T, Zhou J, Li X, Sim K. A novel reductive aminocyclization for the syntheses of chiral pyrrolidines: stereoselective syntheses of (S)-nornicotine adn 2-(2′-pyrrolidyl)-pyridines.Tetrahedron Lett. 1999;40:7847–7850.
Felpin FX, Girard S, Vo-Thanh G, Robins RJ, Villieras J, Lebreton J. Efficient enantiomeric synthesis of pyrrolidine and piperidine alkaloids from tobacco.J Org Chem. 2001;66:6305–6312.
Amat M, Canto M, Llor N, Bosch J. Enantioselective synthesis of 2-arylpiperidines from chiral lactams. A concise synthesis of (−)-anabasine.Chem Comm. 2002;5:526–527.
Balasubramanian T, Hassner A. Asymmetric synthesis of functionalized piperidine derivatives: synthesis of (S)-anatabine.Tetrahedron Asymmetry. 1998;9:2201–2205.
Aiqiao M, Xun X, Lanjun W, Yaozhong J. Asymmetric synthesis XV: enantioselective sytheses of (R) or (S)-alpha-substituted-(2-pyridyl) methylamines via chiral pinanone ketimine template.Synth Comm. 1991;21:2207–2212.
Swango JH, Bhatti BS, Qureshi MM, Crooks PA. A novel enantioselective synthesis of (S)-(−)- and (R)-(+)-nornicotine via alkylation of a chiral 2-hydroxy-3-pinanone ketimine template.Chirality. 1999;11:316–318.
Ayers JT, Sonar VN, Parkin S, Dwoskin LP, Crooks PA. (1R,2R,5R)-(+)-2alfa-hydroxypinan-3-one ketamine.Acta Cryst Sect E. 2005;E61:02682–02684.
Mehmandoust M, Marazano C, Das BC. A stereoselective route to enantiomeric 2-alkyl-1,2,3,6-tetrahydropyridines.J Chem Soc Chem Commun. 1989;1185–1144.
Author information
Authors and Affiliations
Corresponding author
Additional information
Published: October 31, 2005
Rights and permissions
About this article
Cite this article
Ayers, J.T., Xu, R., Dwoskin, L.P. et al. A general procedure for the enantioselective synthesis of the minor tobacco alkaloids nornicotine, anabasine, and anatabine. AAPS J 7, 75 (2005). https://doi.org/10.1208/aapsj070375
Received:
Accepted:
DOI: https://doi.org/10.1208/aapsj070375